A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Cannabidiol (CBD) is an abundant non‐psychoactive phytocannabinoid in cannabis
extracts which has high affinity on a series of receptors, including Type 1 cannabinoid …
extracts which has high affinity on a series of receptors, including Type 1 cannabinoid …
[HTML][HTML] Cannabidiol (CBD) as a promising anti-cancer drug
ES Seltzer, AK Watters, D MacKenzie, LM Granat… - Cancers, 2020 - mdpi.com
Recently, cannabinoids, such as cannabidiol (CBD) and Δ 9-tetrahydrocannabinol (THC),
have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a …
have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a …
From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology
A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …
Cannabidiol, neuroprotection and neuropsychiatric disorders
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders …
[HTML][HTML] Review of the neurological benefits of phytocannabinoids
J Maroon, J Bost - Surgical neurology international, 2018 - ncbi.nlm.nih.gov
Background: Numerous physical, psychological, and emotional benefits have been
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …
Safety and side effects of cannabidiol, a Cannabis sativa constituent
M Machado Bergamaschi… - Current drug …, 2011 - ingentaconnect.com
Cannabidiol (CBD), a major nonpsychotropic constituent of Cannabis, has multiple
pharmacological actions, including anxiolytic, antipsychotic, antiemetic and anti …
pharmacological actions, including anxiolytic, antipsychotic, antiemetic and anti …
Anticancer mechanisms of cannabinoids
In addition to the well-known palliative effects of cannabinoids on some cancer-associated
symptoms, a large body of evidence shows that these molecules can decrease tumour …
symptoms, a large body of evidence shows that these molecules can decrease tumour …
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Δ 9-tetrahydrocannabinol binds cannabinoid (CB 1 and CB 2) receptors, which are activated
by endogenous compounds (endocannabinoids) and are involved in a wide range of …
by endogenous compounds (endocannabinoids) and are involved in a wide range of …
Towards the use of cannabinoids as antitumour agents
Various reports have shown that cannabinoids (the active components of marijuana and
their derivatives) can reduce tumour growth and progression in animal models of cancer, in …
their derivatives) can reduce tumour growth and progression in animal models of cancer, in …
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
A Shrivastava, PM Kuzontkoski, JE Groopman… - Molecular cancer …, 2011 - AACR
Cannabidiol (CBD), a major nonpsychoactive constituent of cannabis, is considered an
antineoplastic agent on the basis of its in vitro and in vivo activity against tumor cells …
antineoplastic agent on the basis of its in vitro and in vivo activity against tumor cells …